Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B.
Tetzlaff MT, et al. Among authors: bell d.
J Pathol. 2016 Sep;240(1):84-95. doi: 10.1002/path.4759.
J Pathol. 2016.
PMID: 27287813